Author:
Okubo Yoshiaki,Mera Toshiyuki,Wang Limei,Faustman Denise L.
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Liyanage, U. K. et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immuno 169, 2756–2761 (2002).
2. Ormandy, L. A. et al. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 65, 2457–2464 (2005).
3. Ichihara, F. et al. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 9, 4404–4408 (2003).
4. Ochs, H. D., Gambineri, E. & Torgerson, T. R. IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Immuno Res 38, 112–121 (2007).
5. Brunkow, M. E. et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature Genetics 27, 68–73 (2001).